IRCT1138901151556N11已完成2 期
Sildenafil add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: Age between 18-55, Diagnosis of Schizophrenia based on DSM IV 3 chronic Schizophrenia, Minimum Score of 60 on Positive and Negative Scale
排除标准
- •Substance dependence, Pregnancy and breast feeding, Any serious medical problem
研究者
相似试验
已完成
不适用
Simvastatin in the treatment of AutismAutistic Disorder.Childhood autismIRCT201602041556N86Tehran University of Medical Sciences40
已完成
2 期
Riluzole in the treatment of autismChildhood autism.Childhood autismIRCT201107281556N27Tehran University of Medical Sciences40
已完成
2 期
Minocycline in the treatment of autismAutistic Disorder.Childhood autismIRCT201302201556N50Tehran University of Medical Sciences40
已完成
不适用
Efficacy of Milrinone Plus Sildenafil in the Treatment of Neonates with Persistent Pulmonary HypertensioPACTR201902691230243Department of Pediatrics Faculty of Medicine University of Alexandria60
招募中
3 期
Investigation of the efficacy of Risperidone in the treatment of developmental stuttering in Persian-speaking children aged 5 to 10 yearsStuttering.Childhood onset fluency disorderF80.81IRCT20240527061909N1Babol University of Medical Sciences30